Contamination Concerns Lead to FDA Warning Against Use of PharmaTech Liquid Products

Evrard Martin
Août 13, 2017

Lymphoma patients can develop pneumonia due to a weakened immune system, so they should be among those avoiding PharmaTech liquid products. The bacteria involved is Burkholderia cepacia, or B. cepacia. According to the Food and Drug Administration, the products were distributed to wholesale and retail facilities, including hospitals and pharmacies. After being alerted to the issue by FDA, Rugby Laboratories issued a voluntary recall on August 3, 2017 of Diocto Syrup and Diocto Liquid (docusate sodium solutions).

The regulatory agency previously had warned against using PharmaTech's oral liquid docusate, after the Centers for Disease Control and Prevention detected a strain of the bacteria in the product following a 2016 multistate outbreak of infections.

"Patients who are using liquid drug products and who have concerns should contact their health care professional", the FDA advises.

However, determining which products were manufactured by PharmaTech could prove hard "because these liquid products are not labeled with a PharmaTech label", the safety alert states.

Three drug distributors on Thursday issued nationwide recalls for all liquid drugs manufactured by PharmaTech, an Athens, Ga. -based drugmaker. You can consult the FDA recall announcement for a list of recalled products with photos.

D'autres rapports CampDesrEcrues

Discuter de cet article

SUIVRE NOTRE JOURNAL